Sherry Collier

Title: Sherry Collier: Innovator in Pharmaceutical Compositions

Introduction

Sherry Collier is a notable inventor based in Flemington, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals and pharmaceutical compositions. With a total of 4 patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Collier's latest patents include innovative compositions and co-crystals. One of her notable inventions is related to co-crystals and pharmaceutical compositions comprising a specific structure that includes (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide and the co-crystal former 4-amino salicylic acid. Additionally, she has developed methods for the preparation of 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and its salts.

Career Highlights

Throughout her career, Sherry Collier has worked with prominent companies in the pharmaceutical industry. She has been associated with H. Lundbeck A/S and Vertex Pharmaceuticals, Inc., where she has contributed her expertise in drug development and formulation.

Collaborations

Collier has collaborated with several professionals in her field, including Heidi Lopez De Diego and Ole Nielsen. These collaborations have likely enhanced her research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Sherry Collier's contributions to pharmaceutical compositions and her innovative patents highlight her role as a significant inventor in the industry. Her work continues to pave the way for advancements in drug development and therapeutic applications.